Synergistic effect of TONS504-mediated photodynamic antimicrobial chemotherapy and additives widely contained in ophthalmic solutions: benzalkonium chloride and ethylenediaminetetraacetic acid
- PMID: 35859250
- DOI: 10.1007/s43630-022-00266-4
Synergistic effect of TONS504-mediated photodynamic antimicrobial chemotherapy and additives widely contained in ophthalmic solutions: benzalkonium chloride and ethylenediaminetetraacetic acid
Abstract
TONS504 (C51H58N8O5I2), a chlorine derivative, effectively generates singlet oxygen by light activation and exhibits photodynamic antimicrobial effects (PAEs) on various pathogens. However, this photosensitizer has some limitations: a high tendency to self-aggregate and a relatively weak PAE for Gram-negative bacteria compared with Gram-positive bacteria. To overcome these limitations, the present study investigated the synergistic effects of the PAE of TONS504 and two additives commonly contained in ophthalmic solutions: benzalkonium chloride (BAC) or ethylenediaminetetraacetic acid (EDTA). Staphylococcus aureus and Pseudomonas aeruginosa were exposed to TONS504 and/or each additive. Photodynamic antimicrobial chemotherapy was performed with light irradiation centered at a wavelength of 665 nm with a total light energy of 30 J/cm2. Following incubation, the number of colonies formed was counted. Additionally, we examined the inhibitory effects of the additives on TONS504 self-aggregation by observing its absorption spectrum. Consequently, the PAEs of TONS504 on S. aureus were enhanced by both additives, and BAC displayed stronger synergistic effects on the bacteria than EDTA. By contrast, only EDTA increased the PAE on P. aeruginosa. The peak of the TONS504 absorption spectrum shifted to a longer wave length and the absorbance increased in the presence of BAC, suggesting that BAC inhibited the self-aggregation of the photosensitizer. In conclusion, the combination of BAC or EDTA and TONS504-mediated photodynamic antimicrobial chemotherapy exhibits a synergistic antimicrobial effect on S. aureus and P. aeruginosa. The optimal additive to enhance the PAE may differ between bacterial strains.
Keywords: Benzalkonium compounds; Edetic acid; Keratitis; Photochemotherapy; Pseudomonas aeruginosa; Staphylococcus aureus.
© 2022. The Author(s), under exclusive licence to European Photochemistry Association, European Society for Photobiology.
Similar articles
-
Molecular characteristics of the photosensitizer TONS504: Comparison of its singlet oxygen quantum yields and photodynamic antimicrobial effect with those of methylene blue.J Photochem Photobiol B. 2021 Aug;221:112239. doi: 10.1016/j.jphotobiol.2021.112239. Epub 2021 Jun 8. J Photochem Photobiol B. 2021. PMID: 34116319
-
In Vitro Efficacy of Photodynamic Antimicrobial Chemotherapy with TONS504 Using Blue Light Against Pseudomonas aeruginosa.Yonago Acta Med. 2024 Oct 7;67(4):284-292. doi: 10.33160/yam.2024.11.001. eCollection 2024 Nov. Yonago Acta Med. 2024. PMID: 39583761 Free PMC article.
-
In Vitro Efficacy Testing of TONS504-Based Photodynamic Antimicrobial Chemotherapy (TONS504-PACT) Under a 405-nm Light-Emitting Diode Against Antimicrobial-Resistant Bacteria Causing Canine Keratitis.Vet Ophthalmol. 2025 May 9. doi: 10.1111/vop.70028. Online ahead of print. Vet Ophthalmol. 2025. PMID: 40346765
-
Applications of Antimicrobial Photodynamic Therapy against Bacterial Biofilms.Int J Mol Sci. 2022 Mar 16;23(6):3209. doi: 10.3390/ijms23063209. Int J Mol Sci. 2022. PMID: 35328629 Free PMC article. Review.
-
Porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria.Eur J Med Chem. 2019 Aug 1;175:72-106. doi: 10.1016/j.ejmech.2019.04.057. Epub 2019 Apr 29. Eur J Med Chem. 2019. PMID: 31096157 Review.
References
-
- Flaxman, S. R., Bourne, R. R. A., Resnikoff, S., Ackland, P., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., Keeffe, J., Kempen, J. H., Leasher, J., Limburg, H., Naidoo, K., Pesudovs, K., Silvester, A., Stevens, G. A., Tahhan, N., Wong, T. Y., & Taylor, H. R. (2017). Global causes of blindness and distance vision impairment 1990–2020: A systematic review and meta-analysis. The Lancet Global Health, 5(12), e1221–e1234. https://doi.org/10.1016/S2214-109X(17)30393-5 - DOI - PubMed
-
- Ung, L., Bispo, P. J. M., Shanbhag, S. S., Gilmore, M. S., & Chodosh, J. (2019). The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance. Survey of Ophthalmology, 64(3), 255–271. https://doi.org/10.1016/j.survophthal.2018.12.003 - DOI - PubMed
-
- Cieplika, F., Deng, D., Crielaard, W., Buchalla, W., Hellwig, E., Al-Ahmad, A., & Maisch, T. (2018). Antimicrobial photodynamic therapy: What we know and what we don’t. Critical Reviews in Microbiology, 44(5), 571–589. https://doi.org/10.1080/1040841X.2018.1467876 - DOI
-
- Wainwright, M. (1998). Photodynamic antimicrobial chemotherapy (PACT). Journal of Antimicrobial Chemotherapy, 42(1), 13–28. https://doi.org/10.1093/jac/42.1.13 - DOI - PubMed
-
- Vatansever, F., de Melo, W. C. M. A., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., Tegos, G. P., & Hamblin, M. R. (2013). Antimicrobial strategies centered around reactive oxygen species: Bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiology Reviews, 37(6), 955–989. https://doi.org/10.1111/1574-6976.12026 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources